View Item 

Show simple item record

Neuroendocrine effects of l -tryptophan and dexamethasone

dc.contributor.authorTräskman-Bendz, Lilen_US
dc.contributor.authorZis, Athanasios P.en_US
dc.contributor.authorHaskett, Roger F.en_US
dc.date.accessioned2006-09-11T17:47:06Z
dc.date.available2006-09-11T17:47:06Z
dc.date.issued1986-05en_US
dc.identifier.citationTräskman-Bendz, Lil; Haskett, Roger F.; Zis, Athanasios P.; (1986). "Neuroendocrine effects of l -tryptophan and dexamethasone." Psychopharmacology 89(1): 85-88. <http://hdl.handle.net/2027.42/46440>en_US
dc.identifier.issn0033-3158en_US
dc.identifier.issn1432-2072en_US
dc.identifier.urihttps://hdl.handle.net/2027.42/46440
dc.identifier.urihttp://www.ncbi.nlm.nih.gov/sites/entrez?cmd=retrieve&db=pubmed&list_uids=3090598&dopt=citationen_US
dc.description.abstractAn infusion of l -tryptophan was administered twice to five healthy male volunteers, once after pretreatment with dexamethasone 1 mg the previous evening and once after no dexamethasone. Cortisol, prolactin, and growth hormone levels were measured, and the responses to l -tryptophan were compared with those seen after an infusion of l -threonine. l -tryptophan did not produce cortisol secretion after dexamethasone, but prolactin and growth hormone responses were noticed. The results demonstrate a stimulatory effect of l -tryptophan on prolactin and growth hormone secretion, and the former is facilitated by pretreatment with dexamethasone.en_US
dc.format.extent408179 bytes
dc.format.extent3115 bytes
dc.format.mimetypeapplication/pdf
dc.format.mimetypetext/plain
dc.language.isoen_US
dc.publisherSpringer-Verlagen_US
dc.subject.otherCortisolen_US
dc.subject.otherBiomedicineen_US
dc.subject.otherPsychiatryen_US
dc.subject.otherDexamethasoneen_US
dc.subject.otherGrowth Hormoneen_US
dc.subject.otherPharmacology/Toxicologyen_US
dc.subject.otherTryptophanen_US
dc.subject.otherProlactinen_US
dc.titleNeuroendocrine effects of l -tryptophan and dexamethasoneen_US
dc.typeArticleen_US
dc.subject.hlbsecondlevelPsychiatryen_US
dc.subject.hlbsecondlevelNeurosciencesen_US
dc.subject.hlbsecondlevelChemistryen_US
dc.subject.hlbsecondlevelBiological Chemistryen_US
dc.subject.hlbtoplevelScienceen_US
dc.subject.hlbtoplevelHealth Sciencesen_US
dc.description.peerreviewedPeer Revieweden_US
dc.contributor.affiliationumDepartment of Psychiatry, University of Michigan, 48109, Ann Arbor, MI, USAen_US
dc.contributor.affiliationumDepartment of Psychiatry, University of Michigan, 48109, Ann Arbor, MI, USAen_US
dc.contributor.affiliationumDepartment of Psychiatry, University of Michigan, 48109, Ann Arbor, MI, USA; Department of Psychiatry, Karolinska Hospital, S-10401, Stockholm, Swedenen_US
dc.contributor.affiliationumcampusAnn Arboren_US
dc.identifier.pmid3090598en_US
dc.description.bitstreamurlhttp://deepblue.lib.umich.edu/bitstream/2027.42/46440/1/213_2004_Article_BF00175195.pdfen_US
dc.identifier.doihttp://dx.doi.org/10.1007/BF00175195en_US
dc.identifier.sourcePsychopharmacologyen_US
dc.owningcollnameInterdisciplinary and Peer-Reviewed


Files in this item

Name:
213_2004_Article_BF00175195.pdf
Size:
398.6KB
Format:
PDF
View/Open

Show simple item record

Remediation of Harmful Language

The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.

Accessibility

If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.